Investors/Oxford Science Enterprises

6 London Mempool companies backed by Oxford Science Enterprises

Rank =47 of 430 on the investor leaderboard. A source says it led a round in 1 of them.

See them on the mapCounts only deals named in a source we fetched

Inner London. Coloured dots are the portfolio, grey dots the rest of the map.

Portfolio by sector

Quantum22 Quantum companies
Health22 Health companies
AI11 AI company
Climate11 Climate company

Portfolio on the map (6)

Natcap£15M
Software platform that helps companies and investors measure, report and act on nature and biodiversity risks, including TNFD and CSRD disclosure.
Climate · Nature risk data · Fastest growing
source: esgtoday.com
Beacon Therapeutics
Clinical-stage gene therapy company developing treatments for retinal diseases such as X-linked retinitis pigmentosa.
Health · Ophthalmic Gene Therapy · Fastest growing
source: beacontx.com
Quantum Motion
Builds quantum computers on standard silicon chip technology, designed to fit in normal data centres.
Quantum · Silicon Quantum Computing · Fastest growing
source: quantummotion.com
RQ Bio
Biotech developing long-acting monoclonal antibodies to prevent seasonal flu and other respiratory viruses.
Health · Antibody Therapeutics · Fastest growing
source: uk.finance.yahoo.com
Prolific$33.4M
Platform supplying vetted human participants for research and for AI model training and evaluation.
AI · Human data for AI · Up and comingLed a round
source: au.finance.yahoo.com
ORCA Computing
Builds photonic quantum computers that run in normal data centres alongside AI and HPC systems.
Quantum · Photonic quantum computing · Up and coming
source: orcacomputing.com

Often alongside

Forbion2 shared

We list Oxford Science Enterprises on a company only when a page we fetched names it as an investor. Its real London portfolio is likely bigger. Know a deal we missed? Suggest a fix with a source. How we count